Open Access Open Access  Restricted Access Subscription or Fee Access

Historical Review of Carcinoma wsr to Aetiology

Gyanendra kumar Gupta, Gagan Devi

Abstract


No one would choose to be diagnosed with cancer. It is perhaps the most dreaded disease of mankind. Regardless of the stage of disease, each individual is a cancer survivor. From the moment of diagnosis and for the rest of his life, that person is engaged in the pursuit of life. Treatment of cancer ranges from the use of powerful chemicals, bursts of radiation to complete removal of tumour and surrounding tissue. Each treatment type brings a certain level of risk, pain and disability to the patient, but malignant cells when left untreated inevitably choke off vital organs and circulation. So in this article an attempt is made to highlight aetiology of Ca. So that we can aware of its cause and help in prevention of carcinoma.


Keywords


Cancer, Cancer Survivor, Radiation, Tumour and Malignant

Full Text:

PDF

References


Abeloff: Clinical Oncology, 3rd ed. Churchill Livingston, 2004. Pp 408413.

Goodman LS, Wintrobe MM, et al. Nitrogen mustard therapy. Use of methyl-bis (betachloroethyl) amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. J Am Med Assoc.1946 Sep 21;132:126-32.

Gilman A. The initial clinical trial of nitrogen mustard. Am J Surg.1963 May;105:574-8.

Gilman A. The biological actions and therapeutic applications of the Bchloroethyl amines and sulfides. Science.1946 Apr 5;103(2675):409-36.

Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA. Temporary remissions in acute leukemia in children produced by folic antagonist, 4aminopteroylglutamic acid (aminopterin). N Engl J Med.1948 Jun 3;238(23):787-93.

Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med.1976 Feb 19;294(8):405-10.

Li MC, Hertz R, Bergenstal DM. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. N Engl J Med 1958 Jul 10;259(2):66-74.

Jaffe N, Link MP, Cohen D, Traggis D, et al. High-dose methotrexate in osteogenic sarcoma. Natl Cancer Inst Monogr.1981 Apr;(56):201-6.

Corbin AS, Buchdunger E, Pascal F, Druker BJ. Analysis of the structural basis of specificity of inhibition of the Abl kinase by STI571. J Biol Chem.2002 Aug 30;277(35):32214-9.

O'Brien SG, Guilhot F, et al. Imatinib compared with interferon and lowdose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med.2003 Mar 13;348(11):994-1004.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Research & Reviews: Journal of Oncology and Hematology